» Articles » PMID: 16202666

Relationship Between Glycosylated Haemoglobin and Mean Plasma Glucose Concentration in Cystic Fibrosis

Overview
Journal J Cyst Fibros
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2005 Oct 6
PMID 16202666
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: HbA(1c) is recommended for monitoring glycaemic control in people with cystic fibrosis-related diabetes (CFRD). However the relationship between HbA(1c) and mean plasma glucose concentration (MPG) has not been established in CFRD, as in other forms of diabetes mellitus.

Methods: 20 people (13 male, 29.7+/-8.8 years, 10 CFRD) with cystic fibrosis (CF) underwent HbA(1c) measurement and 48 h continuous glucose monitoring for estimation of MPG. The relationship between HbA(1c) and MPG was established and compared to the reported relationship for type 1 diabetes.

Results: HbA(1c) was strongly correlated with MPG (R(2)=0.888, p<0.0001) in CF. The relationship of MPG to HbA(1c) was described by the equation MPG=(1.47xHbA(1c))-1.15, giving a 1.47 mmol L(-1) change in MPG per 1% change in HbA(1c). This equation predicts that MPG in people with CF and HbA(1c) <7.0% will be similar to MPG in people with type 1 diabetes who achieve the same HbA(1c) target.

Conclusions: These results imply that HbA(1c)<7.0% will predict good blood glucose control in CF as in type 1 diabetes. However, although HbA(1c) predicts complications in type 1 diabetes, further studies are required to establish the relationship between HbA(1c) and diabetic complications in people with CFRD.

Citing Articles

Comparison of continuous glucose monitoring to reference standard oral glucose tolerance test for the detection of dysglycemia in cystic Fibrosis: A systematic review.

Kumar S, Pallin M, Soldatos G, Teede H J Clin Transl Endocrinol. 2022; 30:100305.

PMID: 36200022 PMC: 9529501. DOI: 10.1016/j.jcte.2022.100305.


Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis.

Khare S, Desimone M, Kasim N, Chan C J Clin Transl Endocrinol. 2021; 27:100290.

PMID: 34917485 PMC: 8669384. DOI: 10.1016/j.jcte.2021.100290.


Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.

Scully K, Sherwood J, Martin K, Ruazol M, Marchetti P, Larkin M J Clin Endocrinol Metab. 2021; 107(4):e1444-e1454.

PMID: 34850006 PMC: 8947309. DOI: 10.1210/clinem/dgab857.


Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.

Tommerdahl K, Brinton J, Vigers T, Nadeau K, Zeitler P, Chan C Pediatr Diabetes. 2019; 20(8):1080-1086.

PMID: 31469470 PMC: 7585935. DOI: 10.1111/pedi.12914.


Hemoglobin A Accurately Predicts Continuous Glucose Monitoring-Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis.

Chan C, Hope E, Thurston J, Vigers T, Pyle L, Zeitler P Diabetes Care. 2018; 41(7):1406-1413.

PMID: 29674323 PMC: 6014540. DOI: 10.2337/dc17-2419.